Sarepta Therapeutics (SRPT) - Market Value

Public company logo of sarepta.com (SRPT)

The visualized price action of Sarepta Therapeutics, Inc. (SRPT) shares on the GURU.Markets platform, reaching 1.62, confirms the company's status as a leader in treating neuromuscular pathologies via RNA modulation. The business relies on exceptional market control over Duchenne muscular dystrophy therapies, creating a unique patient support environment. Development is based on the implementation of digital assistants for genome analysis and bioreactor automation.

SRPT (sarepta.com) Market Value history from 07/04/2022 to 11/17/2026

Sarepta Therapeutics, Inc. - analytical breakdowns and key metrics (SRPT)

- market price and analyst price targets:
- market capitalization indicators:
Fundamental company analysis:SRPT (Sarepta Corp)
Original product of Sarepta Corp

To find fundamental support in Sarepta Therapeutics, Inc. (SRPT), it is essential to consider that demand for Duchenne muscular dystrophy gene therapy is independent of macroeconomics and is instead driven by FDA approvals. By analyzing the company's current market capitalization, an investor assesses the aggregate market value of all shares, which allows for the identification of periods of asset overvaluation and the precise determination of liquidity inflows or outflows.

Analysis of competing companies

Market Capitalization TEM (Tempus AI, Inc)|Market Capitalization Qiagen Group|IONS - Market Value|Market Value repligen.com|RNA: Market Capitalization|Market Valuation CRSP (CRISPR Therapeutics)|Market Value GeneDx Holdings Corp.|Market Capitalization RARE (Ultragenyx Corp)|Market Value Beam Therapeutics (BEAM)|Twist Bioscience - Market Capitalization|Market Capitalization TXG (10x Genomics, Inc.)|Market Capitalization Intellia Therapeutics, Inc. NTLA|STOK - Market Value|BLFS: Market Value|WVE (Wave Life Sciences) - Market Valuation|Maze Therapeutics (MAZE) - Market Capitalization|Market Value Sionna Corp|Prime Medicine Inc (PRME) - Market Capitalization|Market Value Taysha Corp (TSHA)|uniQure N.V. (QURE) - Market Capitalization|Market Capitalization MGTX (MeiraGTx Corp)|RGNX: Market Capitalization|SLDB: Market Valuation|OCGN (Ocugen Corp) - Market Capitalization|PACB: Market Capitalization|Market Valuation Benitec Biopharma Inc.|Market Valuation DSGN|Rocket Pharmaceuticals - Market Valuation|Market Capitalization FDMT|LXEO - Market Value|Korro Bio, Inc. - Market Valuation|EDIT: Market Capitalization|SLN - Market Value|PRQR - Market Capitalization|CDXS (Codexis, Inc.) - Market Valuation|Sangamo Therapeutics, Inc. - Market Value|Market Valuation NAUT|Market Valuation Metagenomi, Inc. (MGX)|Market Value precisionbiosciences.com (DTIL)|GBIO - Market Value|Market Capitalization BOLD (Boundless Bio Inc.)|Market Capitalization Exicure, Inc. XCUR|Imunon Inc - Market Capitalization|Market Capitalization phiopharma.com PHIO|Mustang Bio Corp (MBIO) - Market Value|Market Value TransCode Therapeutics (RNAZ)|BNGO (Bionano Genomics) - Market Capitalization|Market Valuation Applied DNA Sciences, Inc. (APDN)|Market Value Bluebird Bio (BLUE)|IPA - Market Value|Market Value omegatherapeutics.com OMGA|singulargenomics.com (OMIC) - Market Value|RGLS - Market Value|Market Capitalization Syros Pharmaceuticals Inc. SYRS|Telesis Bio, Inc. (TBIO) - Market Value|TCON - Market Capitalization|Market Value Unity Biotechnology, Inc.